Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Nanofat Injection vs PRP or Minoxidil in Androgenetic Alopecia
NCT07518342Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2026
- Primary completion
- Jun 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of microfragmented adipose tissue in androgenetic alopecia (AGA) (3 arms), sponsored by Assiut University. Primary endpoints: Clinical improvement by using trichoscopy and photographs at 16 weeks, Trichoscopic improvement at 16 weeks and 1 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
microfragmented adipose tissue
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07518342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07518342.